1. Home
  2. Browse Decisions
  3. A.3d
  4. 175 A.3d
  5. 175 A.3d 1023 (2017)
 

IN RE RISPERDAL LITIGATION

Nos. 577 EDA 2015, 578 EDA 2015, 579 EDA 2015, 580 EDA 2015, 581 EDA 2015, 582 EDA 2015, 583 EDA 2015, 584 EDA 2015, 585 EDA 2015, 586 EDA 2015, 587 EDA 2015, 588 EDA 2015, 589 EDA 2015.

175 A.3d 1023 (2017)

2017 PA Super 375

IN RE: RISPERDAL LITIGATION Ma.J.L. and M.L., Appellants v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, and Janssen Research and Development, LLC. In re: Risperdal Litigation A.H., Jr. and A.H., Appellants v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, ABD Janssen Research and Development, LLC. In re: Risperdal Litigation Daniel Brewer, Appellant v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, and Janssen Research and Development, LLC. In re: Risperdal Litigation D.A. and B.A., Appellants v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, and Janssen Research and Development, LLC. In re: Risperdal Litigation. K.S., and Sarah Labadie, Appellants, v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, Janssen Research and Development LLC. In re: Risperdal Litigation. Matthew Lanthier, Appellant, v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, Janssen Research and Development, LLC. In re: Risperdal Litigation. Mitchell Lindberg, Appellant, v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, and Janssen Research and Development, LLC. In re: Risperdal Litigation. Mi.J.L. and M.L., Appellants, v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, and Janssen Research and Development, LLC. In re: Risperdal Litigation. Erik Riggs, Appellant, v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, and Janssen Research and Development, LLC. In re: Risperdal Litigation. Scott Wisniewski, Appellant, v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, and Janssen Research and Development, LLC. In re: Risperdal Litigation. Nathan Zachar, Appellant, v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, Janssen Research and Development, LLC. In re: Risperdal Litigation. Danny Woodcock, Appellant, v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, and Janssen Research and Development, LLC. In re: Risperdal Litigation. Cortez Mullen, Appellant, v. Janssen Pharmaceuticals, Inc., Johnson & Johnson Company, and Janssen Research and Development, LLC.

Superior Court of Pennsylvania.

Filed November 28, 2017.

Attorney(s) appearing for the Case

Charles L. Becker , Philadelphia, for appellants.

Robert C. Heim , Philadelphia, for appellees.

BEFORE: PANELLA, J., RANSOM, J., and FITZGERALD, J.

In these consolidated appeals, Appellants, Ma.J.L. and M.L., A.H., Jr. and A.H., Daniel Brewer, D.A. and B.A., K.S. and Sarah LaBadie, Matthew Lanthier, Mitchell Lindberg, Mi.J.L. and M.L., Erik Riggs, Scott Wisniewski, Nathan Zachar, Danny Woodcock, and Cortez Mullen, appeal from the judgments entered in the Philadelphia...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases